NextEye Secures 7.6 Billion KRW Order for Machine Vision Inspection Equipment..."200 Billion KRW Target for This Year"

[Asia Economy Reporter Yoo Hyun-seok] NextEye, a machine vision inspection equipment and cosmetics & beauty specialist company, announced on the 31st that it has secured domestic and international machine vision inspection equipment orders worth a total of 7.6 billion KRW as of May this year.

They explained that the supply of products has normalized as the inspection equipment orders, which were postponed last year due to the impact of COVID-19, have resumed. A NextEye official said, “In the first quarter of this year, we focused on stabilizing networks and supply chains by actively conducting sales to major domestic and international clients,” adding, “Since large-scale orders are expected to begin in earnest from the second quarter, we will achieve this year’s target order amount of over 20 billion KRW through even more aggressive sales activities.”

NextEye supplies industrial machine vision inspection equipment to over 100 companies domestically and internationally, including China’s BOE, Japan’s Nitto Denko, and LG Chem. The equipment can perform inspections such as display polarizing film defect and foreign substance inspection, non-contact 3D measurement inspection for mobile phones, and foreign substance inspection for food containers including instant rice. They are expanding their supply destinations to China, Japan, Vietnam, and other countries.

A company representative said, “We expect meaningful results from each business division this year,” adding, “In the cosmetics and beauty division, we are preparing to launch new products through joint ventures with affiliates, and in the bio business division, which is being promoted as a new business, we are carefully reviewing highly competitive business items in global markets such as China, aiming for successful business progress.”

NextEye has invested 14 billion KRW in ‘Mot Beauty Bio Private Equity Investment Partnership,’ established for the bio business, and has embarked on new business ventures. They plan to create synergy through business cooperation and diversification by investing in promising domestic pharmaceutical and bio companies while generating investment returns.

NextEye’s affiliate, New&New, a cosmetics OEM (Original Equipment Manufacturing), ODM (Original Design Manufacturing), and OBM (Original Brand Manufacturing) specialist company, has signed an IPO underwriting contract with Kiwoom Securities and is preparing for listing on KOSDAQ.

This content was produced with the assistance of AI translation services.